Risk and the dengue vaccine
Department of Health officials went on television the other night to announce the suspension of the government’s antidengue vaccination program. This move was prompted by the admission of Sanofi Pasteur, the pharmaceutical company behind the vaccine, that the administration of “Dengvaxia” could lead to more severe symptoms for people who have not been previously infected. … Read more